Registered Plan Private Investments (Registered Plan Private Investments) Other Net Income (Loss) : $0.00 Mil (TTM As of Dec. 2019)

View and export this data going back to 2017. Start your Free Trial

What is Registered Plan Private Investments Other Net Income (Loss)?

Registered Plan Private Investments's Other Net Income (Loss) for the three months ended in Dec. 2019 was $0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2019 was $0.00 Mil.

Registered Plan Private Investments Other Net Income (Loss) Historical Data

The historical data trend for Registered Plan Private Investments's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Registered Plan Private Investments Other Net Income (Loss) Chart

Registered Plan Private Investments Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Other Net Income (Loss)

Registered Plan Private Investments Quarterly Data
	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19
Other Net Income (Loss)	Get a 7-Day Free Trial											-	-	-	-	-

Registered Plan Private Investments Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Registered Plan Private Investments Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Registered Plan Private Investments's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Registered Plan Private Investments (Registered Plan Private Investments) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Registered Plan Private Investments Inc (OTCPK:LXGTF) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

1055 West Hastings Street, Suite 1900, Vancouver, BC, CAN, V6E 2E9

Website

https://lexingtonbiosciences.com

Registered Plan Private Investments Inc is a private investment platform company that allows investors to use their Registered Plans (including registered retirement savings plans, registered education savings plans, tax-free savings accounts, registered retirement income funds, and registered disability savings plans) at their direction to invest in private companies by purchasing tracking shares in RPPI, which in turn uses these proceeds to invest in the specific private company chosen by the investor.

Registered Plan Private Investments (Registered Plan Private Investments) Headlines

From GuruFocus

Lexington Biosciences Announces Results of Annual General Meeting

By Marketwired Marketwired • 07-03-2018

Lexington Announces First Multicenter Clinical Study Site

By Marketwired Marketwired • 08-21-2018

Lexington Biosciences Announces Termination of Private Placement

By Marketwired Marketwired • 02-15-2019

Lexington Biosciences Provides Update on Financial Situation

By Marketwired Marketwired • 04-02-2019

Lexington Engages with Major Canadian University and Provides Clinical Trial Update

By Marketwired Marketwired • 05-08-2018

Lexington Provides Q3 Corporate Review

By Marketwired Marketwired • 10-24-2018

Lexington Biosciences Receives HeartSentry USPTO Patent Approval

By Marketwired Marketwired • 07-25-2018

Lexington Releases Audited Consolidated Financial Statements

By Marketwired Marketwired • 05-01-2018